HIGHLIGHTS OF PRESCRIBING INFORMATION DOSAGE AND ADMINISTRATION ADVERSE REACTIONS

First Page		Document Content
Date: 2014-08-21 13:04:53 Olopatadine Contact lens Alcohols Azelastine Chemistry Organic chemistry Amines		HIGHLIGHTS OF PRESCRIBING INFORMATION DOSAGE AND ADMINISTRATION ADVERSE REACTIONS Add to Reading List Source URL: ecatalog.alcon.com Download Document from Source Website File Size: 439,27 KB Share Document on Facebook

	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PAZEO* safely and effectively. See full prescribing information for PAZEO. PAZEO (olopatadine hydrochloride ophthalm DocID: 1rcmh - View Document
	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PAZEO* safely and effectively. See full prescribing information for PAZEO. PAZEO (olopatadine hydrochloride ophthalm DocID: 1qJA3 - View Document
	DESCRIPTION PATANOL® (olopatadine hydrochloride ophthalmic solution) 0.1% is a sterile ophthalmic solution containing olopatadine, a relatively selective H1 -receptor antagonist and inhibitor of histamine release from t DocID: NAo0 - View Document
	Division: Pharmacy Services Subject: Prior Authorization Criteria Original Development Date: Original Effective Date: DocID: COdJ - View Document
	CPDO Examination - Minicase 1 Patient findings: A 27-year-old female presents after an airbag injury to her right eye the previous day. Examination reveals a relative afferent pupillary defect and light-perception vision DocID: CO0u - View Document